{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-009150","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2023-12-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.765445+00:00","generated_at":"2026-06-07T05:46:48.468103+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Sonoma Pharmaceuticals grants 180,000 stock options to executive officers at $0.18 per share","bullets":["CEO Amy Trombly, interim CFO Jerry Dvonch, and COO Bruce Thornton each received 60,000 options.","Exercise price of $0.18 is based on December 29, 2023 closing price.","Options vest in three equal annual tranches; non-employee directors waived their grants.","All options fully vest upon a change of control.","Total options granted to executive officers: 180,000."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-009150","json":"https://secwatch.observer/filing/0001683168-23-009150.json","markdown":"https://secwatch.observer/filing/0001683168-23-009150.md","text":"https://secwatch.observer/filing/0001683168-23-009150.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823009150/0001683168-23-009150-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823009150/sonoma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T05:46:48.468103+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}